Evidence map›Paper›PMID 17037540›Full record

ArticleAdvances in experimental medicine and biology2006

Human coronavirus 229E can use CD209L (L-SIGN) to enter cells.

Scott A Jeffers, Erin M Hemmila, Kathryn V Holmes

Abstract read
In one paragraph

Article in Advances in experimental medicine and biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2.bioRxiv : the preprint server for biology · 2021
    Article
  9. Review
  10. Review
  11. Article
  12. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?International journal of molecular sciences · 2021
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Coronaviruses' sugar shields as vaccine candidates.Current trends in immunology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Scott A JeffersUniversity of Colorado Health Sciences Center at Fitzsimons, Aurora, USA.
Erin M Hemmila
Kathryn V Holmes

Funding

Virus Propagation and InoculationP01AI059576 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLMES, KATHRYN V · 2004 to 2009
$9.0M
NIAID NIH HHS 1 T32 AI07587NIAID NIH HHS AI59576
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin-Converting Enzyme 2AnimalsCD13 AntigensCell Adhesion MoleculesCell LineCHO CellsCoronavirus 229E, HumanCricetinaeDendritic CellsFlow CytometryHumansLectins, C-TypeMicePeptidyl-Dipeptidase AProtein BindingReceptors, Cell SurfaceACE2 protein, humanAce2 protein, mouseAngiotensin-Converting Enzyme 2CD13 AntigensCell Adhesion MoleculesCLEC4M protein, humanLectins, C-TypePeptidyl-Dipeptidase AReceptors, Cell Surface

Identifiers

PMID17037540
PMCPMC7123611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.